Лечение табачной зависимости с помощью никотинозаместительной терапии как один из методов снижения риска сердечно-сосудистых заболеваний
Диссертация
Для оценки вероятности успешного отказа от вредной привычки целесообразно выяснять особенности статуса курения (выраженность никотиновой зависимости — в первую очередь, время от утреннего подъема до закуривания первой сигареты и возникновение дискомфорта при вынужденной абстиненцииинтенсивность и стаж курения), а также социального окружения пациентов (курение членов семьи и коллег). При отказе… Читать ещё >
Список литературы
- Александров А.А. Эпидемия курения и подходы к борьбе с ней. Новости науки и техники. Сер. Мед. Вып. Табачная зависимость и курение табака. ВИНИТИ. 1999, 1:3−10.
- Александров А.А., Александрова В. Ю., Ваганов А. Д. и соавт. Изучение распространенности курения среди подростков основа разработки мероприятий по профилактике сердечно-сосудистых заболеваний. Кардиоваскулярная терапия и профилактика 2003:2(1)-65−9.
- Александров А.А., Прохоров А. В., Александрова В. Ю. Организация курения среди детей и подростков. Здравоохранение РФ 19 921:18−21.
- Гамбарян М.Г. Изучение взаимосвязей факторов риска хронической обструктивной болезни легких и оптимизация ее профилактики: управление риском, связанным с курением табака. Автореф.. .канд. мед. наук. М 2002- 26 с.
- Левшин В.Ф. Проблема табакокурения и пути ее решения. Курение или здоровье в России? Серия докладов по политике в области охраны здоровья населения «Здоровье для всех все для здоровья» под ред. А. К. Демина. — М.-1996.-№ 3.-С. 157−212.
- Моль X. Семь программ здоровья. 2-е изд.- пер. с нем. М.- Физкультура и спорт, 1983 — 64 с.
- Оганов Р.Г., Деев А. Д., Жуковский Г. С., и соавт. Влияние курения на смертность от хронических неинфекционных заболеваний по результатам проспективного исследования. Профилактика заболеваний и укрепление здоровья 1998−3:13−5.
- Организация проведения лечения табакокурения лицам, находящимся в общесоматических больницах. Методические рекомендации. МЗ СССР. Управление наркологии ГУ ЛПП. Проблемная комиссия «Табакокурение» НС по наркологии АМН СССР. Москва, 1987. 20 с.
- Российский статистический ежегодник. 2002. Стат. сб. / Госкомстат России. М., 2002. — 690 с.
- Сарсенова С.И. Сравнительное изучение эффективностинемедикаментозных и медикаментозных методов прекращения курения в амбулаторных условиях. Автореф. дис. .канд. мед. наук. М 1993- 27 с.
- Сидоренко Г. И. Реальна ли эффективная борьба с табакокурением? Кардиология 2002−7:76−9.
- Тимофеева С.Г. Борьба с курением среди студентов как составная часть комплекса мероприятий ранней профилактики сердечно-сосудистых заболеваний. Автореф. дис. .канд. мед. наук. М 1991- 29 с.
- Чучалин А.Г., Сахарова Г. М. Практическое применение программ по лечению табачной зависимости. РМЖ 2002- 10(4): 149−53.
- Чучалин А.Г., Сахарова Г. М., Новиков К. Ю. Практическое руководство по лечению табачной зависимости. РМЖ 2001−9(21):904−10.
- Шальнова С.А. Факторы риска сердечно-сосудистых заболеваний и показатели ожидаемой продолжительности жизни населения России. Дис.. док1. мед. наук. М 2000- 191 с.
- Шальнова С.А., Деев А. Д., Оганов Р. Г. Распространенность курения в России. Результаты обследования национальной представительной выборки населения. Профилактика заболеваний и укрепление здоровья 1998−3:9−12.
- Abbot NC, Stead LF, White AR, Ernst E. Hypnotherapy for smoking cessation. In: Cochrane Collaboration. Cochrane Library. Issue 3. Oxford: Update Software, 2000.
- Adams MR, Jessup W, Celermajer DS. Cigarette smoking is associated with increased human monocyte adhesion to endothelial cells: reversibility with oral1. arginine but not vitamin C. J Am Coll Cardiol 1997−29:491−7.
- Allred EN, Bleecker ER, Chaitman BR, et al. Short-term effects of carbon monoxide exposure on the exercise performance of subjects with coronary artery disease. N Engl J Med 1989−321:1426.
- Anda RF, Remington PL, Sienko DG, Davis RM. Are physicians advising smokers to quit? The patient’s perspective. JAMA 1987−257:1916−9.
- Bazzano LA, He J, Muntner P, et al. Relationship between cigarette smoking and novel risk factors for cardiovascular disease in the United States. Ann Intern Med 2003−138 (ll):891−7.
- Benowitz NL, Fitzgerald GA, Wilson M, Zhang Q. Nicotine effects on eicosanoid formation and hemostatic function: comparison of transdermal nicotine and cigarette smoking. J Am Coll Cardiol 1993−22(4): 1159−67.
- Benowitz NL, Gourlay SG. Cardiovascular toxicity of nicotine: implications for nicotine replacement therapy. J Am Coll Cardiol 1997−29(7): 1422−31.
- Blondal T, Gudmundsson LJ, Olafsdottir I, et al. Nicotine nasal spray with nicotine patch for smoking cessation: randomised trial with six year follow up. BMJ 1999−318(7179):285−8.
- Bolliger CT, Zellweger JP, Danielsson T, et al. Smoking reduction with oral nicotine inhalers: double blind, randomised clinical trial of efficacy and safety. BMJ 2000−321:329−33.
- Bolliger CT, Zellweger JP, Danielsson T, et al. Influence of long-term smoking reduction on health risk markers and quality of life. Nicotine Tob Res 2002−4(4):433−9.
- Bostrom L, binder LE, Bergstrom J. Smoking and cervicular fluid levels of IL-6 and TNF-alpha in periodontal disease. J Clin Periodontol 1999−26(6):352−7.
- Burke AP, Farb A, Malcolm GT, et al. Coronary risk factor and plaque morphology in men with coronary disease who died suddenly. N Engl J Med 1997−3j6, 1276−82.
- Burns D, Shanks T, Major J, et al. Evidence on disease risks in public health conseq iences of low yield cigarettes. Smoking and Tobacco Control Monograph 13. Washington, DC: National Cancer Institute (in press).
- Campisi R, Czernin J, Schoder H, et al. Effects of long-term smoking on myocardial blood flow, coronary vasomotion and vasodilator capacity. Circulation 1998−98:119−25.
- Celermajer DS, Sorensen KE, Georgakopoulos D, et al. Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation 1993−88:2149−55.
- Cromwell J, Bartosch WJ, Fiore MC, et al. Cost-effectiveness of the clinical practice recommendations in the AHCPR guideline for smoking cessation. Agency for Health Care Policy and Research. JAMA 1997−278(21): 1759−66.
- Czernin J, Sun K, Brunken R, et al. Effect of acute and long-term smoking on myocardial blood flow and flow reserve. Circulation 1995−91:2891.
- Dale L. Higher doses of NRT? Abstracts of the 4th European Conference of the Society for Research on Nicotine and Tobacco, 3−5 October 2002, Santander, Spain. P. 7.
- Dale LC, Schroeder DR, Wolter TD, et al. Weight change after smoking cessation using variable doses of transdermal nicotine replacement. J Gen Intern Med 1998−13(1):9−15.
- Dawber TR. The Framingham Study: The Epidemiology of Atherosclerotic Disease. Chapter 8. Cambridge, MA: Harvard University Press, 1980.
- DeMatt MP, Pietersma A, Kofflard M, et al. Association of plasma fibrinogen levels with coronary artery disease, smoking and inflammatory markers. Atherosclerosis 1996- 121:185.
- Doherty K, Militello FS, Kinnunen T, Garvey AJ. Nicotine gum dose and weight gain after smoking cessation. J Consult Clin Psychol 1996−64(4):799−807.
- Duthie GG, Arthur JR, Beattie JA, et al. Cigarette smoking antioxidants, lipid peroxidation, and coronary heart disease. An N Y Acad Sci 1993−686:120−9.
- Eliasson B, Attvall S, Taskinen MR, Smith U. Smoking cessation improves insulin sensitivity in healthy middle-aged men. Eur J Clin Invest 1997−27(5):450−6.
- Eliasson B, Hjalmarson A, Kruse E, et al. Effect of smoking reduction and cessation on cardiovascular risk factors. Nicotine Tobacco Research 2001−3(3):249−55.
- Etter JF, Perneger TV, Ronchi A. Distributions of smokers by stage: international comparison and association with smoking prevalence. Prev Med 1997- 26(4):580−5.
- Fagerstrom КО. Measuring degree of physical dependence to tobacco smokingwith reference to individualization of treatment. Add Behav 1978−3:235−41.
- Fagerstrom КО. Nicotine dose selection using «time to first cigarette». Abstracts of the 4th European Conference of the Society for Research on Nicotine and Tobacco, 3−5 October 2002, Santander, Spain. P. 22.
- Fagerstrom КО, Tejding R, Westin A, Lunell E. Aiding reduction of smoking with nicotine replacement medications: hope for the recalcitrant smoker? Tobacco Control 1997−6:311−6.
- Ferno O. A substitute for tobacco smoking. Psychopharmacologia 1973- 31(3):201−4.
- Fiore MC, Baily WC, Cohen SJ, et al. Treating Tobacco Use and Dependence. Clinical Practice Guideline. Rockville, MD: U.S. Department of Health and Human Services. Public Health Service. June 2000.
- Fortmann SP, P. ogers T, Vranizan K, et al. Indirect measures of cigarette use: expired-air carbon monoxide versus plasma thiocyanate. Prev Med 1984−13(1): 127−35.
- Galan KM, Deligonul U, Kern MJ, et al. Increased frequency of restenosis in patients continuing to smoke cigarettes after percutaneous transluminal coronary angioplasty. Am J Cardiol 1998−61(4):260−3.
- Gariti P, Alterman Al, Ehrman R, et al. Detecting smoking following smoking cessation treatment. Drug Alcohol Depend 2002−65(2): 191−6.
- Godtfredsen NS, Osier M, Vestbo J, et al. Smoking reduction, smoking cessation, and incidence of fatal and non-fatal myocardial infarction in Denmark 1976−1998: a pooled cohort study. J Epidemiol Comm Health 2003−57:412−6.
- Gordon T, Kannel WB, Dawber TR, McGee D. Changes associated with quitting cigarette smoking: the Framingham Study. Am Heart J 1975−90(3):322−8.
- Gourlay SG, Forbes A, Marriner T, et al. Prospective study of factors predicting outcome of transdermal nicotine treatment in smoking cessation. BMJ 1994−309(6958):842−6.
- Greene SB, Aavedal MJ, Tyroler HA, et al. Smoking habits and blood pressure change: a seven year follow-up. J Chronic Dis 1977−30(7):401−13.
- Halimi JM, Giraudeau B, Vol S, et al. The risk of hypertension in men: direct and indirect effects of chronic smoking. J Hypertens 2002−20:187−93.
- Hankey GJ. Smoking and risk of stroke. J Cardiovasc Risk 1999−6:207−11.
- Haustein КО. Tobacco or Health? Physiological and Social Damages Caused by Tobacco Smoking. Chapter 6. Cardiovascular Disease, Disturbances of Blood coagulation and fibrinolysis. Springer, 2003. P. 118.
- Haustein КО. Tobacco or Health? Physiological and Social Damages Caused by Tobacco Smoking. Chapter 14. Society, Politics and the Tobacco Industry. Springer, 2003. P.414.
- Herrera N, Franco R, Herrera L, et al. Nicotine gum, 2 and 4 mg, for nicotine dependence. A double-blind placebo-controlled trial within a behaviormodification support program. Chest 1995−108(2):447−51.
- Hill AL, Roe DJ, Taren DL, et al. Efficacy of transdermal nicotine in reducing post-cessation weight gain in a Hispanic sample. Nicotine Tob Res 2000−2(3):247−53.
- Hill C. Trends in tobacco smoking and consequences on health in France. Prev Med 1998 -27(4):514−9.
- Howard G, Wagenkneht LE, Cai J, et al. Cigarette smoking and other risk factors for silent cerebral infarction in the general population. Stroke 1998−29:913−7.
- Hughes J. Applying harm reduction to smoking. Tob Control 1995−4(suppl 2):533−8.
- Hughes JR. Four beliefs that may impede progress in the treatment of smoking. Tob Control 1999−8:323−6.
- Hughes JR, Cummings KM, Hyland A. Ability of smokers to reduce then-smoking and its association with future smoking cessation. Addiction 1999−94(1): 109−14.
- Hughes JR, Gulliver SB, Fenwick JW, et al. Smoking cessation among self-quitters. Health Psychol 1992- 11(5):331−5.
- Hughes JR, Lesmes GR, Hatsukami DK, et al. Are higher doses of nicotine replacement more effective for smoking cessation? Nicotine Tob Res 1999- 1(2): 169−74.
- IOM (Institute of Medicine). State Programs Can Reduce Tobacco Use. Washington, DC: National Academy Press, 2000.
- Istvan J A, Lee WW, Buist AS, Connett JE. Relation of salivary cotinine to blood pressure in middle-aged cigarette smokers. Am Heart J 1999- 137(5):928−31.
- Jarvis MJ. Patterns and predictors of smoking in the general population. In: The tobacco epidemic. Eds Bolliger CT, Fagerstrom КО. Basel, Karger, 1997. Pp. 151−64.
- Jarvic MJ, Tunstall-Pedoe H, Feyerabend C, et al. Comparison of tests used to distinguish smokers from nonsmokers. Am J Pub Health 1987−77(11): 1435−8.
- Jimenez-Ruiz C, Kunze M, Fagerstrom КО. Nicotine replacement: a new approach to reducing tobacco-related harm. Eur Respir J 1998- 11(2):473−9.
- Joseph AM, Norman SM, Ferry LH, et al. The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease. N Engl J Med 1996−335(24): 1794−8.
- Kahn HA, Sempos CJ. Statistical methods in epidemiology. Chapter 4. Attributable Risk. Oxford University Press, 1989. P. 73.
- Kannel WB, McGee DL, Castelli WP. Latest perspectives on cigarette smoking and coronary heart disease. The Framingham Study. Journal of Cardiac Rehabilitation 1984−4:267.
- Khoury Z, Comans P, Keren A, et al. Effects of transdermal nicotine patches on ambulatory ECG monitoring findings: a double-blind study in healthy smokers. Cardiovasc Drugs Ther 1996−10(2): 179−84.
- Kornitzer M, Boutsen M, Dramaix M, et al. Combined use of nicotine patch and gum in smoking cessation: a placebo-controlled clinical trial. Prev Med 1995−24(l):41−7.
- Kornitzer M, Kittel F, Dramaix M, Bourdoux P. A double-blind study of 2 mg versus 4 mg nicotine-gum in an industrial setting. J Psychosom Res 1987−31(2): 171−6.
- Kottke T, Battista RN, DeFriese GH, Brekke ML. Attributes of successful smoking cessation interventions in medical practice. A meta-analysis of 39 controlled trials. JAMA 1988−259(19):2883−9.
- Kunze M. Harm reduction: the possible role of nicotine replacement. In: The tobacco epidemic. Eds Bolliger CT, Fagerstrom КО. Basel, Karger, 1997. Pp. 190−98.
- Lancaster T, Stead LF. Individual behavioural counselling for smoking cessation. In: Cochrane Collaboration. Cochrane Library. Issue 3. Oxford: Update Software, 2000.
- Lancaster T, Stead LF. Self-help interventions for smoking cessation. In: Cochrane Collaboration. Cochrane Library. Issue 3. Oxford: Update Software, 2000.
- Lancaster T, Stead L, Silagy C, Sowden A. Effectiveness of interventions to help people stop smoking: findings from the Cochrane Library. BMJ 2000- 321(7257):355−8.
- Law M, Tang JL. An analysis of the effectiveness of interventions intended to help people stop smoking. Arch Intern Med 1995−155:1933−41.
- Lee DH, Ha MH, Kim JR, Jacobs DR Jr. Effects of smoking cessation on changes in blood pressure and incidence of hypertension. Hypertens 2001−37:194−8.
- Leischow SJ, Sachs DP, Bostrom AG, Hansen MD. Effects of differing nicotine-replacement doses on weight gain after smoking cessation. Arch Fam Med 1992-l (2):233−7.
- Mahmarian JJ, Moye LA, Nasser GA, et al. Nicotine patch therapy in smoking cessation reduces the extent of exercise-induced myocardial ischemia. J Am Coll Cardiol 1997−30(1): 125−30.
- Manderbacka K, Lundberg O, Martikainen P. Do risk factors and health behaviours contribute to self-ratings of health? Soc Sci Med 1999−48(12):1713
- McGinnis JM, Foege WH. Mortality and morbidity attributable to use of addictive substances in the United States. Proc Assoc Am Physicians 1999−111(2): 109−18.
- McNamara P, Lawson JA, Rokach J, FitzGerald GA. F2 and E2 isoprostanes are ligands for peroxisome prolifer-activated receptors. FASEB J 1999−13:A1549.
- McNeil A, Hendrie A, in consultation with the expert group. Regulation of nicotine replacement therapies: an expert consensus. The WHO European Partnership Project to Reduce Tobacco Dependence. WHO Regional Office for Europe. Copenhagen 2001.
- Mikkelsen KL, Winberg N, Hoegholm A, et al. Smoking related to 24-h ambulatory blood pressure and heart rate: a study in 352 normotensive Danish subjects. Am J Hypertens 1997−10(5 Pt 1):483−91.
- Minami J, Ishimitsu T, Matsuoka H. Effects of smoking cessation on blood pressure and heart rate variability in habitual smokers. Hypertension 1999−33(1 Pt 2):586−90.
- Morrow JD, Frei B, Longmire AW, et al. Increase in circulation products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage. N Engl J Med 1995−332(18): 1198−203.
- Mulder I, Tijhuis M, Smith HA, Kromhout D. Smoking cessation and quality of life: the effect of amount of smoking and the time since quitting. Prev Med 2001−33(6):653−60.
- Murray RP, Bailey WC, Daniels K, et al. Safety of nicotine polacrilex gum usedby 3,094 participants in the Lung Health Study. Lung Health Study Research Group. Chest 1996−109(2):438−45.
- National Institute for Clinical Excellence. Guidance on the use of nicotine replacement therapy (NRT) and bupropion for smoking cessation. Technology Appraisal Guidance No 39. National Institute for Clinical Excellence, 2002.
- Newby DE, Wright RA, Labinjoh C, et al. Endothelial dysfunction, impaired endogenous fibrinolysis, and cigarette smoking: a mechanism for arterial thrombosis and myocardial infarction. Circulation 1999−99:1411.
- Nides M, Rand C, Dolce J, et al. Weight gain as function of smoking cessation and 2 mg-nicotine gum use among middle-aged smokers with mild lung impairment in the first 2 years of the Lung Health Study. Health Psychol 1994- 13(4): 354−61.
- Okubo Y, Miyamoto T, Suwazono Y, et al. An association between smoking habits and blood pressure in normotensive Japanese men. J Human Hypertens 2002−16:91−6.
- Palmer JR, Rosenberg L, Shapiro S. «Low yield» cigarettes and the risk of nonfatal myocardial infarction in women. N Engl J Med 320:1569−1573, 1989.
- Park E, Schultz JK, Tudiver F, et al. Enhancing partner support to improve smoking cessation. Cochrane Database Syst Rev 2002−1:CD0029228.
- Parrot S, Godfrey C, Raw M, et al, for the Health Educational Authority. Guidance for commissioners on the cost effectiveness of smoking cessation interventions. Thorax 1998−53(suppl 2):S1-S38.
- PDAY (Pathobiological Determinants of Atherosclerosis in Youth) Research
- Group: Relationship of atherosclerosis in young men to serum lipoprotein cholesterol concentrations and smoking. JAMA 1990−264:3018−24.
- Peto R. Smoking and death: the past 40 years and the next 40. BMJ 1994−309:937−9.
- Peto R, Lopez AD, Boreham J, et al. Mortality from smoking worldwide. Br Med Bull 1996−52(1): 12−21.
- Primatesta P, Falaschetti E, Gupta S, et al. Association between smoking and blood pressure. Evidence from the Health survey for England. Hypertension 2001−37(2): 187−93.
- Probstfield JL. How cost-effective are new preventive strategies for cardiovascular disease? Am J Cardiol 2003−91(10A):22−7.
- Prochaska JO, Di Clemente SS. Stages and processes of self-change in smoking. Towards an integrative model of change. J Consult Clin Psychol 1983−51:390−5.
- Prochaska JO, Goldstein MG. Process of smoking cessation. Implications for clinicians. Clin Chest Med 1991−12(4):727−35.
- Pryor WA. Cigarette smoke radicals and the role of free radicals in chemical carcinogenicity. Environ Health Perspect 1997- 105 Suppl 4(l):875−82.
- Ramstrom L. Cost-effectiveness of smoking cessation procedures. In: Freour P, Masironi R, Quaranta A (eds.): Economic Issues of Smoking and Smoking and
- Smoking Cessation. Proceedings of the Third EMASH Seminar, October 22−24, 1992. Geneva, Switzerland, European Medical Association Smoking or Health, 1992, pp. 15−24.
- Raw M, McNeill A, West R. Smoking cessation guidelines for health professionals. Thorax 1998−53 Suppl.5:l-18.
- Reed DM, MacLean CJ, Hayashi T. Predictors of atherosclerosis in the Honolulu Heart Program: I. Biologic, dietary and lifestyle characteristics. Am J Epidemiol 1987−126:214−25.
- Reilly M, Delanty N, Lawson J A, FitzGerald GA. Modulation of oxidant stress in vivo in chronic cigarette smokers. Circulation 1996−94(1): 19−25.
- Reis RP, Azinheira J, Reis HP, et al. Influence of smoking on homocysteinemia at baseline and after methionine load. Rev Port Cardiol 2000- 19(4):471−4.
- Riise T, Moen BE, Nortverdt MW. Occupation, lifestyle factors and health-related quality of life: the Hordaland Health Study. J Occup Environ Med 2003−45(3):324−32.
- Rivers JT, White HD, Cross DB, et al. Reinfarction after thrombolytic therapy for acute myocardial infarction followed by conservative management: Incident and effect of smoking. J Am Coll Cardiol 1990−16:340−8.
- Rosenberg L, Kaufman DW, Helrich SP, et al. The risk of myocardial infarction after quitting smoking in men under 55 years of age. N Engl J Med 1985−313:1511−4.
- Royal College of Physicians. Nicotine addiction in Britain. London: Pitman Medical, 2000.
- SAS/STAT User’s Guide, Version 6, Fourth Edition, Vol.1 & 2, SAS Institute Inc., Cary, NC, USA, -1990.
- Schneider NG, Olmstead RE, Franzon MA, Lunell E. The nicotine inhaler: clinical pharmacokinetics and comparison with other nicotine treatments. Clin Pharmacokinet 2001−40(9):662−84.
- Shiffman S, Rolf CN, Hellebusch SJ, Gorsline J, et al. Real-world efficacy of prescription and over-the-counter nicotine replacement therapy. Addiction 2002−97:505−16.
- Silagy C, Mant D, Fowler G, Lancaster T. Nicotine replacement therapy for smoking cessation. In: Cochrane Collaboration. Cochrane Library. Issue 3. Oxford: Update Software, 1999.
- Smith С J, Livingston SD, Doolittle DJ. An international literature survey of 'IARS group I carcinogens' reported in mainstream cigarette smoke. Food Chem Toxicol 1997−35:1107−30.
- Song F, Raftery J, Aveyard P, et al. Cost-effectiveness of pharmacological interventions for smoking cessation: a literature review and a decision analytic analysis. Med Decis Making 2002−22(5 Suppl):S26−37.
- Stapleton JA, Lowin A, Russell MAH. Prescription of transdermal nicotine patches for smoking cessation in general practice: evaluation of cost-effectiveness. Lancet 1999−354:208−13.
- Stead LF, Lancaster T. Group behaviour therapy programmes for smoking cessation. In: Cochrane Collaboration. Cochrane Library. Issue 3. Oxford: Update Software, 2000.
- Stookey GK, Katz BP, Olson BL, et al. Evaluation of biochemical validation measures in determination of smoking status. J Dent Res 1987−66(10): 1597−601.
- Swan GE, Carmelli D. Characteristics associated with excessive weight gain after smoking cessation in men. Am J Pub Health 1995−85(l):73−7.
- Tahtinen TM, Vanhala MJ, Oikarinen J A, Keinanen-Kiukaanniemi SM. Effect of smoking on the prevalence of insulin resistance-associated cardiovascular risk factors among Finnish men in military service. J Cardiovasc Risk 1998−5(5−6):319−23.
- Takizawa H, Tanaka M, Takami K, et al. Increased expression of inflammatory mediators in small-airway epithelium from tobacco smokers. Am J Physiol Lung Cell Mol Physiol 2000−278(5):L906−13.
- Targher G, Alberiche M, Zenere MB, et al. Cigarette smoking and insulin resistance in patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1997−82(ll):3619−24.
- Tashkin DP, Kanner R, Bailey W, et al. Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trial. Lancet 2001−357:1571−75
- Terres W, Becker P, Rosenberg A. Changes in cardiovascular risk profile during thp cessation of smoking. Am J Med 1994−97(3):242−9.
- Thun MJ, Day-Lally CA, Calle EE, et al. Excess mortality among cigarette smokers: changes in a 20-year interval. Am J Public Health 1995−85(9): 1223−30.
- Tonnesen P. Nicotine replacement and other drugs in smoking cessation, b- The tobacco epidemic. Eds Bolliger CT, Fagerstrom КО. Basel, Karger, 1997. Pp. 178−89.
- Tzivoni D, Keren A, Meyler S, et al. Cardiovascular safety of transdermal nicotine patches in patients with coronary artery disease who try to quit smoking. Cardiovasc Drugs Ther 1998−12(3):239−44.
- Ueda K, Kawachi I, Nakamura M, et al. Cigarette nicotine yields and nicotine intake among Japanese male workers. Tobacco Control 2002−11:55−60.
- U.S. DHHS (U.S. Department of Health and Human Services). The health consequences of smoking: Cardiovascular Disease. Chapter 8. Washington, DC: DHHS Publications, 1983.
- U.S. DHHS (U.S. Department of Health and Human Services). The Health Consequences of Smoking: 25 Years of Progress. A Report of the Surgeon General. Chapter 8. Washington, DC: DHHS Publications, 1989.
- Ussher MH, West R, Taylor AH, McEwen A. Exercise interventions for smoking cessation. In: Cochrane Collaboration. Cochrane Library. Issue 3. Oxford: Update Software, 2000.
- Vogt TM, Selvin S, Widdowson G, Hulley SB. Expired air carbon monoxide and serum thiocyanate as objective measures of cigarette exposure. Am J Pub Health 1977−67(6):545−9.
- Waage H, Silsand T, Urdal P, Langard S. Discrimination of smoking status by thiocyanate and cotinine in serum, and carbon monoxide in expired air. Int J Epidemiol 1992−21(3):488−93.
- Warner KE. Cost effectiveness of smoking-cessation therapies. Pharmacoeconomics 1997−11:538−49.
- Wasley MA, McNagny SE, Philips VL, et al. The cost-effectiveness of the nicotine transdermal patch for smoking cessation. Prev Med 1997−26:264−70.
- Westman E, Tomlin K, Rose J. Combining the nicotine inhaler and nicotine patch for smoking cessation. Am J Health Behav 2000−24(2):114−9.
- White AR, Rampes H, Ernst E. Acupuncture for smoking cessation. In: Cochrane Collaboration. Cochrane Library. Issue 3. Oxford: Update Software, 2000.
- Wilhelmsen L. Coronary heart disease: Epidemiology of smoking and intervention studies of smoking. Am Heart J 1988- 115:242−9.
- Wilson D, Parsons J, Wakefield M. The health-related quality-of-life of never smokers, ex-smokers, and light, moderate, and heavy smokers. Prev Med 1999−29(3): 139−44.
- Wilson К, Gibson N, Willan A, Cook D. Effect of smoking cessation on mortality after myocardial infarction: meta-analysis of cohort studies. Arch Intern Med 2000−160:939−44.
- Wood-Baker R. Outcome of a smoking cessation programme run in a routine hospital setting. Intern Med J 2002−32(l-2):24−8.
- Woodward M, Tunstall-Pedoe H, Smith WC, Tavendale R. Smoking chaiacteristics and inhalation biochemistry in the Scottish population. J Clin Epidemiol 1991−44(12): 1405−10.
- Woolacott NF, Jones L, Forbes CA, et al. The clinical effectiveness and cost-effectiveness of bupropion and nicotine replacement therapy for smoking cessation: a systematic review and economic evaluation. Health Technol Assess 2002−6(16): 1−245.
- Working Group for the Study of Transdermal Nicotine in Patients with Coronary Artery Disease. Nicotine replacement therap) for patients with coronary artery disease. Arch Intern Med 1994−154:989−95.
- World Health Organization. International statistical classification of diseases and related health problems (ICD-10). 10th rev. Ed., vol. 1. Geneva: World Health Organization, 1992.
- Yamaguchi Y, Kagota S, Haginaka J, Kunitomo M. Peroxynitrite-generating species: good candidate oxidants in aequeous extracts of cigarette smoke. Jpn J Pharmacol 2000−82(1):78−81.
- Yudkin PL, Jones L, Lancaster T, Fowler GH. Which smokers are helped to give up smoking using transdermal nicotine patches? Results from a randomized, double-blind, placebo-controlled trial. Br J Gen Pract 1996−46(404): 145−8.
- Yusuf S, Peto R, Lewis J, et al. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis 1985−27:335−71.
- Zevin S, Jacob P 3rd, Benowitz NL. Dose-related cardiovascular and endocrine effect of transdermal nicotine. Clin Pharmacol Ther 1998−64:87−95.